Advanced search
Publication Cover
Renal Failure Volume 31, 2009 - Issue 9
Submit an article Journal homepage
1,113
Views
12
CrossRef citations to date
0
Altmetric
Case Reports

Membranoproliferative Glomerulonephritis Associated with Psoriasis Vulgaris

Hadim Akoglu Department of Nephrology, Ankara Numune Research and Education Hospital, Ankara, TurkeyCorrespondence[email protected]
,
Fatih Dede Department of Dermatology, Halil Sivgin Cubuk State Hospital, Ankara, Turkey
,
Gulsen Akoglu Department of Pathology, Gazi University School of Medicine, Ankara, Turkey
,
Ipek Isık Gonul Department of Nephrology, Ankara Numune Research and Education Hospital, Ankara, Turkey
&
Ali Rıza Odabas Department of Nephrology, Ankara Numune Research and Education Hospital, Ankara, Turkey
Pages 858-861 | Received 18 May 2009, Accepted 08 Jul 2009, Published online: 19 Nov 2009

REFERENCES

  • Gudjonsson JE, Elder JT. Psoriasis: Epidemiology. Clin Dermatol. 2007;25(6):535–546.
  • Whittam LR, McGibbon DH. The management of psoriasis. Int J Clin Pract. 1998;52(7):487–491.
  • Szepietowski JC, Szepietowski T. Is renal function altered in patients with psoriasis vulgaris? J Dermatol. 2000;27(9): 569–572.
  • Cecchi R, Seghieri G, Gironi A, Tuci F, Giomi A. Relation between urinary albumin excretion and skin involvement in patients with psoriasis. Dermatology. 1992;185(2):93–95.
  • Ahuja TS, Funtanilla M, de Groot JJ, Velasco A, Badalamenti J, Wilson S. IgA nephropathy in psoriasis. Am J Nephrol. 1998;18(5):425–429.
  • Panasiuk NN, Mukhin NA, Varshavskii VA, . The clinico-morphological characteristics of psoriatic nephropathy. Ter Arkh. 1990;62(6):99–103.
  • Singh NP, Prakash A, Kubba S, . Psoriatic nephropathy—does an entity exist? Ren Fail. 2005;27(1):123–127.
  • Kim M, Ko Y, Yeo UC, Kim Y, Oh H. Psoriasis and glomerulonephritis. Clin Exp Dermatol. 1998;23(6):295–296.
  • Yamamoto M, Yorioka T, Kawada M, . A case of IgA nephropathy associated with psoriasis vulgaris. Nippon Jinzo Gakkai Shi. 1994;36(6):779–783.
  • Jiao Y, Xu H, Li H, Li X. Mesangial proliferative glomerulonephritis with or without IgA deposits: The morphological characters in psoriasis vulgaris. Nephron Clin Pract. 2008; 108(3):c221–c225.
  • Sakemi T, Hayashida R, Ikeda Y, Baba N, Nishihara G, Kohda H. Membranous glomerulonephropathy associated with psoriasis vulgaris. Nephron. 1996;72(2):351–352.
  • Kaji T, Tsukada Y, Shimada A, . Membranous nephropathy associated with psoriasis vulgaris. Clin Nephrol. 1994; 42(1):63–64.
  • Powles AV, Cook T, Hulme B, . Renal function and biopsy findings after 5 years’ treatment with low-dose cyclosporin for psoriasis. Br J Dermatol. 1993;128(2):159–165.
  • Grcevska L, Polenaković M, Ferluga D, Vizjak A, Stavrić G. Membranous nephropathy with severe tubulointerstitial and vascular changes in a patient with psoriatic arthritis treated with non-steroidal anti-inflammatory drugs. Clin Nephrol. 1993;39(5):250–253.
  • Zadrazil J, Tichý T, Horák P, . IgA nephropathy associated with psoriasis vulgaris: A contribution to the entity of “psoriatic nephropathy.” J Nephrol. 2006;19(3):382–386.
  • Chalmers RJ, Ead RD, Whale K, Ive FA. Guttate psoriasis, glomerulonephritis and streptococcal infection. Arch Dermatol. 1983;119(12):956.
  • Alenius GM, Stegmayr BG, Dahlqvist SR. Renal abnormalities in a population of patients with psoriatic arthritis. Scand J Rheumatol. 2001;30(5):271–274.
  • Heuvels J, Maximus A, Bosmans JL, Lambert J, De Broe ME. Renal abnormalities in psoriatic patients: A review. Nephron. 1999;82(1):1–6.
  • Markham T, Watson A, Rogers S. Adverse effects with long-term cyclosporin for severe psoriasis. Clin Exp Dermatol. 2002;27(2):111–114.
  • Weinblatt ME, Coblyn JS, Fox DA, . Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med. 1985; 312(13):818–822.
  • Wittenberg GP, Oursler JR, Peters MS. Secondary amyloidosis complicating psoriasis. J Am Acad Dermatol. 1995;32(3): 465–468.
  • Klein M, Radhakrishnan J, Appel G. Cyclosporine treatment of glomerular diseases. Annu Rev Med. 1999;50:1–15.
  • Zelichowski G, Nowosławski A, Wawer Z, Wańkowicz Z. Evaluation of cyclosporin A efficacy in the treatment of steroid-resistant nephrotic syndrome in the course of membranoproliferative glomerulonephritis. Pol Arch Med Wewn. 2001;106(5):1065–1069.
  • Matsumoto H, Shibasaki T, Ohno I, . Effect of cyclosporin monotherapy on proteinuria in a patient with membranoproliferative glomerulonephritis. Nippon Jinzo Gakkai Shi. 1995;37(4):258–262.
  • Erbay B, Karatan O, Duman N, Ertuğ AE. The effect of cyclosporine in idiopathic nephrotic syndrome resistant to immunosuppressive therapy. Transplant Proc. 1988;20(3 Suppl. 4):289–292.
  • Bagheri N, Nemati E, Rahbar K, Nobakht A, Einollahi B, Taheri S. Cyclosporine in the treatment of membranoproliferative glomerulonephritis. Arch Iran Med. 2008;11(1):26–29.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.